| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/06/2013 | US8501764 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus) |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501423 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 08/06/2013 | US8501264 Papaya puree and uses thereof |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | CA2844264A1 Optimized antigens of pneumocystis and use thereof |
| 08/06/2013 | CA2732620C Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 08/06/2013 | CA2690686C Amine compound and pharmaceutical use thereof |
| 08/06/2013 | CA2689696C Microemulsions with adsorbed macromolecules and microparticles |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/06/2013 | CA2326685C Enhancing immune responses to genetic immunization by using a chemokine |
| 08/01/2013 | WO2013112456A1 Controlled release formulations for the induction and proliferation of blood cells |
| 08/01/2013 | WO2013111729A1 Pharmaceutical composition and quasi-drug cosmetic using same |
| 08/01/2013 | WO2013110890A1 New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/01/2013 | WO2013110309A1 Triazolo[4,5-d]pyrimidine derivatives |
| 08/01/2013 | WO2013110163A1 Compositions and methods of modulating an immune response |
| 08/01/2013 | WO2013083813A3 Modulators of spermine/spermidine n'-acetyltransferase (ssat) and ssat associated proteins for use in prevention or treatment of rheumatoid arthritis |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |
| 08/01/2013 | US20130195960 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 08/01/2013 | CA2856443A1 Vaccines against clostridium difficile comprising recombinant toxins |
| 07/31/2013 | EP2620452A1 Binding members for IGE molecules |
| 07/31/2013 | EP2620431A1 Novel crystals of substituted phenylalkanoic acid and production process |
| 07/31/2013 | EP2620156A2 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
| 07/31/2013 | EP2619190A1 Substituted oxadiazole compounds and their use as s1p1 agonists |
| 07/31/2013 | EP2618842A1 Novel immunostimulatory method |
| 07/31/2013 | EP2618666A1 Novel dihydropyrimidin-2(1h)-one compounds as neurokinin-3 receptor antagonists |
| 07/31/2013 | CN103228654A Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as JAK inhibitors |
| 07/31/2013 | CN103228643A Benzazole derivatives as histamine H4 receptor ligands |
| 07/31/2013 | CN103228283A Oil-in-water emulsion composition containing difluprednate and tobramycin |
| 07/31/2013 | CN103228159A Fat composition for programming immune response |
| 07/31/2013 | CN103224895A A novel strain of lactobacillus Reuteri for use by improving autoimmune diseases |
| 07/31/2013 | CN103224562A Epitope regions of a thyrotrophin (TSH) receptor, and antibodies thereto |
| 07/31/2013 | CN103224497A Inhibitors of protein kinases |
| 07/31/2013 | CN103224492A 14-aryl-ether andrographolide derivative and preparation method and application thereof |
| 07/31/2013 | CN103223177A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 07/31/2013 | CN103223175A Scar and tissue fibration resistant oligomeric double-stranded nucleotide medicine and its application |
| 07/31/2013 | CN103223167A Methods of reducing eosinophil levels |
| 07/31/2013 | CN103223165A Reducer of immunosuppression by tumor cell and antitumor agent using the same |
| 07/31/2013 | CN103223132A Medicine for treating allergic dermatitis and preparation method thereof |
| 07/31/2013 | CN103223093A Bone-nourishing body-building oral liquid and preparing method |
| 07/31/2013 | CN103223070A Drug composition for treating hypersensitivity and preparation method thereof |
| 07/31/2013 | CN103223067A Traditional Chinese medicinal preparation for treating chronic urticaria |
| 07/31/2013 | CN103223055A Healthcare product or medicinal composition, and preparation method and uses thereof |
| 07/31/2013 | CN103223038A Traditional Chinese medicine composition for warming kidney and invigorating spleen and preparation method thereof |
| 07/31/2013 | CN103222998A Comprehensive extracting method for platycodin and polysaccharide |
| 07/31/2013 | CN103222997A Traditional Chinese medicine epimedium total flavonoid phosphorylation molecular modification method |
| 07/31/2013 | CN103222994A Medicinal or healthcare food composition for improving immune function, and preparation method thereof |
| 07/31/2013 | CN103222987A Food mineral supplement capable of effectively treating lupus erythematosus |
| 07/31/2013 | CN103222980A Environment-friendly chick immunopotentiator |
| 07/31/2013 | CN103222955A Stable solution containing epinastine or hydrochloride of epinastine |
| 07/31/2013 | CN102670991B Preparation method for dendrobium nobile extractum |
| 07/31/2013 | CN102451163B Polyporus polysaccharide dispersible tablets, and preparation method thereof |
| 07/31/2013 | CN102391225B Mycophenolic acid derivatives Penicacids A, B, C and their application in preparing immunosuppression medicaments |
| 07/31/2013 | CN102343022B Beautifying deer fetus particle and preparation method thereof |
| 07/31/2013 | CN102293806B Method for extracting total flavonoid active part from Huai chrysanthemum and application of total flavonoid active part |
| 07/31/2013 | CN102218084B Traditional Chinese medicament health preserving preparation having effects of enhancing immunity, resisting ageing and improving sub-health |
| 07/31/2013 | CN102210663B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 07/31/2013 | CN101883584B Allergen desensitization method |
| 07/31/2013 | CN101861317B Antihistaminic and antiallergic agent and a method for the production thereof |
| 07/31/2013 | CN101528749B Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/31/2013 | CN101039691B Compositions and methods for treating neurological disorders |
| 07/30/2013 | US8497300 Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/30/2013 | CA2483917C Formulations limiting spread of pulmonary infections |
| 07/25/2013 | WO2013110050A1 Inulin and inulin acetate formulations |
| 07/25/2013 | WO2013109904A1 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 07/25/2013 | WO2013109104A1 Pharmaceutical composition comprising human-blood-derived blood-cell mass |
| 07/25/2013 | WO2013108921A1 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013107609A1 Systemic administration forms with controlled release and improved stability |
| 07/25/2013 | WO2013107413A1 Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| 07/25/2013 | WO2013107326A1 NEW-TYPE IMIDAZO [1, 2-a] PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013106934A1 Novel regulators of innate immunity and uses thereof |
| 07/25/2013 | WO2013043070A3 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 07/25/2013 | WO2013030778A3 Organic compositions to treat hsf1-related diseases |
| 07/25/2013 | WO2012167944A8 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy |
| 07/25/2013 | WO2012156219A9 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189318 Solid dispersions comprising tacrolimus |
| 07/25/2013 | US20130189296 COMPOSITION FOR USE IN INHIBITING OR KILLING Phrphyromonas gingivalis AND USE IN APPLICATIONS FOR ALLEVIATING OR TREATING PERIDONTAL DISEASE AND RELATED DISEASES |
| 07/25/2013 | US20130189240 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/24/2013 | EP2617737A1 High purity heparin and production method therefor |
| 07/24/2013 | EP2617711A1 Amino alcohol derivatives, salts thereof and immunosuppressive agents |
| 07/24/2013 | EP2617435A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |
| 07/24/2013 | EP2617426A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 07/24/2013 | EP2616812A1 Methods of treating autoimmune diseases with anti-fceri antibodies |
| 07/24/2013 | EP2616480A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN103221391A Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |